Search research articles
Contact Us
Filters
Showing results (1-10 of 234) with videos related to
Page
of 24
Sort By:
European Urology Oncology
|
February 28, 2024
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re: Piet Ost, Shankar Siva, Sugmund Brabrand, et al. PEACE V-Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007
Thomas Zilli, Piet Ost
Prostate Cancer and Prostatic Diseases
|
April 29, 2022
Prostate cancer intensity-modulated radiotherapy and long term genitourinary toxicity: an evolving therapeutic landscape
Vérane Achard, Thomas Zilli
Prostate Cancer and Prostatic Diseases
|
February 6, 2025
Stereotactic body radiotherapy: a second chance for radio-recurrent prostate cancer
Nicolas Vial, Thomas Zilli
The Journal of Urology
|
May 11, 2015
Re: Prophylactic Sildenafil Citrate Improves Select Aspects of Sexual Function in Men Treated with Radiotherapy for Prostate Cancer: M. J. Zelefsky, D. Shasha, R. D. Branco, M. Kollmeier, R. E. Baser, X. Pei, R. Ennis, R. Stock, N. Bar-Chama and J. P. Mulhall J Urol 2014; 192: 868-874
Thomas Zilli, Raymond Miralbell
Prostate Cancer and Prostatic Diseases
|
August 13, 2024
Current status and perspectives on the use of androgen receptor pathway inhibitors in the salvage radiotherapy setting
Vérane Achard, Thomas Zilli
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 2024
Toxicity After Prostate Radiation Therapy: Addressing the Transurethral Resection of the Prostate (TURP) Challenge
Ragu Ratnakumaran, Thomas Zilli
Prostate Cancer and Prostatic Diseases
|
November 25, 2025
Chasing the Culprit: targeting metastatic index lesions in oligometastatic hormone-sensitive prostate cancer
Salvatore Cozzi, Thomas Zilli
Oncotarget
|
October 23, 2018
Metastasis-directed therapy: a new standard for oligorecurrent prostate cancer?
Thomas Zilli, Piet Ost
International Journal of Radiation Oncology, Biology, Physics
|
February 15, 2015
High-dose salvage radiation therapy for prostate cancer after relapse: in regard to D'Angelillo et al
Thomas Zilli, Raymond Miralbell
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 2020
In Regard to Qi et al
Vérane Achard, Thomas Zilli
Page
of 24
Search research articles
Search
Showing results (1-10 of 234) with videos related to
Sort By:
Page
of 24
European Urology Oncology
|
February 28, 2024
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re: Piet Ost, Shankar Siva, Sugmund Brabrand, et al. PEACE V-Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007
Thomas Zilli, Piet Ost
Prostate Cancer and Prostatic Diseases
|
April 29, 2022
Prostate cancer intensity-modulated radiotherapy and long term genitourinary toxicity: an evolving therapeutic landscape
Vérane Achard, Thomas Zilli
Prostate Cancer and Prostatic Diseases
|
February 6, 2025
Stereotactic body radiotherapy: a second chance for radio-recurrent prostate cancer
Nicolas Vial, Thomas Zilli
The Journal of Urology
|
May 11, 2015
Re: Prophylactic Sildenafil Citrate Improves Select Aspects of Sexual Function in Men Treated with Radiotherapy for Prostate Cancer: M. J. Zelefsky, D. Shasha, R. D. Branco, M. Kollmeier, R. E. Baser, X. Pei, R. Ennis, R. Stock, N. Bar-Chama and J. P. Mulhall J Urol 2014; 192: 868-874
Thomas Zilli, Raymond Miralbell
Prostate Cancer and Prostatic Diseases
|
August 13, 2024
Current status and perspectives on the use of androgen receptor pathway inhibitors in the salvage radiotherapy setting
Vérane Achard, Thomas Zilli
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 2024
Toxicity After Prostate Radiation Therapy: Addressing the Transurethral Resection of the Prostate (TURP) Challenge
Ragu Ratnakumaran, Thomas Zilli
Prostate Cancer and Prostatic Diseases
|
November 25, 2025
Chasing the Culprit: targeting metastatic index lesions in oligometastatic hormone-sensitive prostate cancer
Salvatore Cozzi, Thomas Zilli
Oncotarget
|
October 23, 2018
Metastasis-directed therapy: a new standard for oligorecurrent prostate cancer?
Thomas Zilli, Piet Ost
International Journal of Radiation Oncology, Biology, Physics
|
February 15, 2015
High-dose salvage radiation therapy for prostate cancer after relapse: in regard to D'Angelillo et al
Thomas Zilli, Raymond Miralbell
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 2020
In Regard to Qi et al
Vérane Achard, Thomas Zilli
Page
of 24